As former ONE flyweight kickboxing world champion Ilias Ennahachi prepares for a pivotal kickboxing bout at ONE 171: Qatar ...

Clearwater Analytics' $1.5 billion acquisition of Enfusion is a strategic move to expand its portfolio management offerings and enhance its SaaS revenue growth. Enfusion's strong business model ...

BOISE, Idaho & CHICAGO, January 13, 2025--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today ...

Jan 13 (Reuters) - Clearwater Analytics (CWAN.N), opens new tab has agreed to acquire Enfusion (ENFN.N), opens new tab in a $1.5 billion cash-and-stock deal as the financial software maker looks ...

(RTTNews) - Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion shareholders will receive consideration equal to $ ...

Clearwater, which says it has obtained an $800 million loan to fund the transaction, along with a $200 million revolving line of credit, will let Enfusion’s shareholders elect to receive cash ...

(Reuters) -Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge ...

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in ...

The two firms have inked a definitive merger agreement for Clearwater to acquire Enfusion for $11.25 per share, delivered in an approximately equal mix of cash and stock. Clearwater will also pay ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares closed yesterday at $11.07. Discover outperforming ...

Clearwater Analytics has agreed to acquire rival Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge fund ...

Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.